RRM2 and breast carcinoma: Tackling this head on, the current study aimed to elucidate the role of miR-4500 in breast cancer and uncovered that miR-4500 inactivates the MAPK signaling pathway through downregulation of RRM2, thus restricting the development of breast cancer.